共 17 条
- [1] WHAT COURSE OF ACTION SHALL WE TAKE WHEN FINDING A POSITIVE HCV SEROLOGY IN A BLOOD-DONOR [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 315 - 342
- [2] WHAT COURSE OF ACTION SHALL WE TAKE WHEN DISCOVERING SYPHILITIC SEROLOGY IN A BLOOD-DONOR [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 351 - 352
- [3] WHAT COURSE OF ACTION SHALL WE TAKE WHEN FINDING A BIOLOGICAL DISORDER IN A BLOOD-DONOR [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 295 - 304
- [4] WHAT COURSE OF ACTION SHALL WE TAKE WHEN DISCOVERING LOW HEMATOCRIT OR DECREASED HEMOGLOBIN LEVEL IN A BLOOD-DONOR [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 343 - 349
- [6] ABSENCE OF HTLV-I/II INFECTION IN BLOOD-DONORS WITH POSITIVE AND INCONCLUSIVE HTLV-I/II SEROLOGY [J]. MICROBIOLOGICA, 1992, 15 (04): : 329 - 336
- [7] HTLV-I - NEWEST ADDITION TO BLOOD-DONOR SCREENING [J]. AMERICAN FAMILY PHYSICIAN, 1989, 40 (02) : 189 - 195
- [8] EXPERIENCE WITH ONE-YEAR OF BLOOD-DONOR SCREENING FOR HTLV-I/II IN DENMARK [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (02): : 151 - 151
- [9] A RETROSPECTIVE STUDY OF ANTI-HTLV-I/II ANTIBODIES IN A BLOOD-DONOR [J]. PRESSE MEDICALE, 1991, 20 (16): : 771 - 771
- [10] WHAT COURSE OF ACTION SHALL WE TAKE WHEN DISCOVERING SERIC MARKERS OF INFECTION BY THE HEPATITIS-B VIRUS (HBS-ANTIGEN AND OR ANTI-HBC ANTIBODY) - HIGH TRANSAMINASES LEVEL OR BOTH DISORDERS IN A BLOOD-DONOR [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 285 - 294